Zepp Health

Zepp Health Debt/EBITDA

The Total Debt to EBITDA Ratio of Zepp Health (ZEPP) as of Nov 2, 2026 is -4.75. In the previous year, Total Debt to EBITDA Ratio was -2.20 — a change of 116.03% (lower).

Debt/EBITDA

-4.75

YoY

116.03%

Last updated:

Total Debt to EBITDA Ratio of Zepp Health is 2025 -4.75 . Total Debt to EBITDA Ratio of Zepp Health was 2024 -2.20 . It decreases by 116.03% lower compared to the previous year.

The Zepp Health Debt/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt/EBITDA
Date
Debt/EBITDA
Jan 1, 2018
0.10 USD
Jan 1, 2019
0.06 USD
Jan 1, 2020
3.71 USD
Jan 1, 2021
13.77 USD
Jan 1, 2022
-4.03 USD
Jan 1, 2023
-6.46 USD
Jan 1, 2024
-2.20 USD
Jan 1, 2025
-4.75 USD
The Zepp Health Debt/EBITDA history
YEARDebt/EBITDAYoY
-4.75+116.03%
-2.20-65.96%
-6.46+60.50%
-4.03-129.22%
13.77+270.93%
3.71+6,542.38%
0.06-45.51%
0.10-48.95%
0.20-77.78%
0.90-279.93%
-0.50—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Zepp Health Stock analysis

What does Zepp Health do? Zepp Health Corporation generates revenue through its consumer brands Amazfit, Zepp Clarity, and Zepp Aura, offering smart wearables and health technology products globally. Its product portfolio includes smart bands, watches, rings, hearables, the Helio Strap, smart scales, and accessories, alongside sportswear and home appliances. The company sells these under the Amazfit and Zepp brand names in around 90 countries, targeting health-conscious individuals seeking fitness and wellness solutions. Zepp Aura provides personalized sound health solutions for emotional regulation and sports performance, integrated with data analysis via Zepp Life and Zepp mobile apps. Zepp Health’s primary customers are consumers interested in optimizing their health and fitness journeys, purchasing devices like smart bands and watches through its branded offerings. The company’s revenue streams include direct sales of hardware products and digital health services, with Zepp Aura serving as a premium service for real-time biometric data analysis. Products are distributed internationally, leveraging the Amazfit and Zepp brand presence in approximately 90 countries. The business model relies on recurring engagement through mobile apps that display activity and biometric data, enhancing user retention and encouraging additional product purchases. Zepp Clarity and Zepp Aura are positioned as high-value services within the health technology ecosystem, complementing the physical hardware sales. The company’s strategy focuses on building a comprehensive wellness platform that integrates wearable devices with personalized health insights. Zepp Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Zepp Health stock

Total Debt to EBITDA Ratio of Zepp Health is -4.75 in 2025.

Total Debt to EBITDA Ratio of Zepp Health changed from -2.20 to -4.75, representing a 116.03% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Debt to EBITDA Ratio Zepp Health since 2006 – with annual values, charts, and detailed analysis.

Debt/EBITDA measures total debt relative to earnings before interest, taxes, depreciation, and amortization. It indicates the years needed to repay all debt from EBITDA.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Total Debt to EBITDA Ratio's Zepp Health with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Zepp Health

All Key Metrics — Zepp Health